Alto Neuroscience ANRO
NYSE ANRO
$23.78 -0.63 (-2.56%)
As of: Oct 21, 2026 · 2:47 PM EDT

Alto Neuroscience (ANRO) Common Stock Issued (2023 - 2026)

Updated

Analysis

Alto Neuroscience (ANRO) Common Stock Issued (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn -
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 359.00 Mn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn -
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn -
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 6.00 Mn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn -
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn 9.00 Mn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn -
10 Alto Neuroscience 1.02 Bn 197.58 Mn - 75,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 75,000.00
Mar 31, 2026 6,000.00
Dec 31, 2025 352,000.00
Sep 30, 2025 153,000.00
Mar 31, 2025 198,000.00
Dec 31, 2024 49,000.00
Sep 30, 2024 67,000.00
Jun 30, 2024 61,000.00
Mar 31, 2024 137.59 Mn
Dec 31, 2023 29,000.00
Sep 30, 2023 109,000.00
Jun 30, 2023 43,000.00
API Access

Alto Neuroscience Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ANRO&period=max&api_key=YOUR_API_KEY